A Study of EMD525797 in Solid Tumor Patients in Japan

NCT01327313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: EMD525797
BIOLOGICAL: EMD525797
BIOLOGICAL: EMD525797
BIOLOGICAL: EMD525797

Sponsor

Merck KGaA, Darmstadt, Germany